The Rash

Pas encore noté

A Stanford public-health professor speaks out against pharmaceutical institutions exploiting a mysterious rash outbreak through a drug that makes people forget about it.

Pays d'origine
États-Unis
Budget
6 000 000 $US

Équipe technique